All Stories

  1. Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations

    Article • PLoS ONE, November 2023, PLOS

    BM Gurupadayya

  2. Combinatorial Implications of Nrf2 Inhibitors with FN3K Inhibitor: In vitro Breast Cancer Study

    Article • Current Pharmaceutical Design, August 2023, Bentham Science Publishers

    Mikhail Sinelnikov, BM Gurupadayya

  3. Chiral Separation of Oxomemazine Enantiomers by HPLC Technique and Enantiomeric Separation Mechanism via Docking Studies

    Article • Current Pharmaceutical Analysis, January 2021, Bentham Science Publishers

    BM Gurupadayya

  4. Analysis of Orphenadrine Citrate in Various Chiral Stationary Phases: A Comparative Study

    Article • Current Chromatography, December 2020, Bentham Science Publishers

    BM Gurupadayya, subramanyam s

  5. Bioanalytical Method Development of Atenolol Enantiomers: Stereoselective Behavior in Rabbit Plasma by RP-UFLC Method

    Article • Current Pharmaceutical Analysis, December 2019, Bentham Science Publishers

    BM Gurupadayya